| Literature DB >> 36216977 |
Bram Roudijk1, Ayesha Sajjad2, Brigitte Essers3, Stefan Lipman2, Peep Stalmeier4, Aureliano Paolo Finch5.
Abstract
BACKGROUND ANDEntities:
Year: 2022 PMID: 36216977 PMCID: PMC9549846 DOI: 10.1007/s40273-022-01192-0
Source DB: PubMed Journal: Pharmacoeconomics ISSN: 1170-7690 Impact factor: 4.558
Sample characteristics of the cTTO and DCE samples
| cTTO | DCE | Dutch general population (%) | |
|---|---|---|---|
| Female | 113 (57.4) | 491 (51.2) | 50.7% |
| Male | 84 (42.6) | 467 (48.7) | 49.4% |
| Other | 0 (0) | 1 (0.1) | Not reported |
| 18–24 | 21 (10.7) | 98 (10.2) | 10.9% |
| 25–34 | 52 (26.4) | 146 (15.2) | 15.9% |
| 35–44 | 41 (20.8) | 135 (14.1) | 14.7% |
| 45–54 | 38 (19.3) | 168 (17.5) | 17.1% |
| 55–64 | 29 (14.7) | 164 (17.1) | 17.0% |
| 65+ | 16 (8.1) | 248 (25.9) | 24.4% |
| Low | 12 (6.1) | 75 (7.8) | 29.2% |
| Lower middle | 63 (32.0) | 360 (37.5) | 27.8% |
| Upper middle | 83 (42.1) | 409 (42.7) | 30.7% |
| University | 39 (19.8) | 115 (12.0) | 12.3% |
| Married/registered partners | 113 (57.4) | 506 (52.8) | 45.7% |
| Single | 72 (36.5) | 306 (31.9) | 39.2% |
| Divorced | 9 (4.6) | 82 (8.5) | 9.2% |
| Widowed | 3 (1.5) | 43 (4.5) | 5.8% |
| Prefer not to say | 0 (0) | 22 (2.3) | |
| Yes | 105 (53.3) | 545 (56.8) | N/A |
| No | 92 (46.7) | 414 (43.2) | N/A |
| <€14.000 | 17 (8.6) | 71 (7.4) | N/A |
| €14.000–€27.999 | 22 (11.2) | 182 (19.0) | N/A |
| €28.000–€41.999 | 34 (17.3) | 198 (20.6) | N/A |
| €42.000–€55.999 | 30 (15.2) | 141 (14.7) | N/A |
| €56.000–€69.999 | 23 (11.7) | 98 (10.2) | N/A |
| €70.000–€90.999 | 16 (8.1) | 50 (5.2) | N/A |
| >€91.000 | 13 (6.6) | 46 (4.8) | N/A |
| Refuse to answer | 42 (21.3) | 173 (18.1) | N/A |
Frequencies are reported first, followed by percentages of the total sample in brackets. The last column only reports the percentage of the Dutch population [24]
CTTO composite time trade-off, DCE discrete choice experiment, N/A data not available
Responses to the EQ-5D-5L questionnaire for the cTTO and DCE samples
| cTTO ( | DCE ( | |
|---|---|---|
| No problems | 178 (90.4) | 718 (74.9) |
| Slight problems | 10 (5.1) | 171 (17.8) |
| Moderate problems | 6 (3.0) | 40 (4.2) |
| Severe problems | 3 (1.5) | 27 (2.8) |
| Unable to | 1 (0.0) | 3 (0.3) |
| No problems | 196 (99.5) | 907 (94.6) |
| Slight problems | 1 (0.5) | 34 (3.5) |
| Moderate problems | 0 (0) | 13 (1.4) |
| Severe problems | 0 (0) | 5 (0.5) |
| Unable to | 0 (0) | 0 (0.0) |
| No problems | 157 (79.7) | 695 (72.5) |
| Slight problems | 28 (14.2) | 175 (18.2) |
| Moderate problems | 11 (5.6) | 65 (6.8) |
| Severe problems | 1 (0.5) | 20 (2.1) |
| Unable to | 0 (0.0) | 4 (0.4) |
| No problems | 122 (61.9) | 483 (50.4) |
| Slight problems | 58 (29.4) | 337 (35.1) |
| Moderate problems | 15 (7.6) | 107 (11.2) |
| Severe problems | 2 (1.0) | 31 (3.2) |
| Extreme problems | 0 (0.0) | 1 (0.1) |
| No problems | 155 (78.7) | 668 (69.7) |
| Slight problems | 35 (17.8) | 199 (20.7) |
| Moderate problems | 7 (3.5) | 63 (6.6) |
| Severe problems | 0 (0.0) | 25 (2.6) |
| Extreme problems | 0 (0.0) | 4 (0.4) |
CTTO composite time trade-off, DCE discrete choice experiment
Fig. 1Distribution of cTTO responses
Modelling results of cTTO data
| Random intercept regression | Heteroskedastic model | Heteroskedastic model, intercept constrained at 1 | |
|---|---|---|---|
| mo2 | 0.003 | 0.028* | −0.036** |
| mo3 | −0.102** | −0.086** | −0.090** |
| sc2 | −0.022 | −0.020 | −0.025* |
| sc3 | −0.105** | −0.065** | −0.069** |
| ua2 | −0.023 | −0.034** | −0.041** |
| ua3 | −0.130** | −0.103** | −0.108** |
| pd2 | −0.037 | −0.047** | −0.052** |
| pd3 | −0.450** | −0.450** | −0.453** |
| ad2 | −0.070** | −0.062** | −0.066** |
| ad3 | −0.503** | −0.493** | −0.496** |
| Constant | 0.989@ | 0.984@ | 1.000 |
| Observations | 1970 | 1970 | 1970 |
| Respondents | 197 | 197 | 197 |
| AIC | 2160 | 1545 | 1545 |
The rows represent the coefficient level dimensions (e.g. mo2 represents mobility level 2)
AIC Akaike Information Criterion, CTTO composite time trade-off, * indicates significance at the 5% level, ** indicates significance at the 1% level, @ indicates constants in these models did not significantly differ from 1
Modelling results of DCE data
| Conditional logit | Mixed logit | Conditional logit rescaled | Mixed logit rescaled | |
|---|---|---|---|---|
| mo2 | − 0.386** | − 0.587** | − 0.048** | − 0.036** |
| mo3 | − 1.890** | − 3.146** | − 0.235** | − 0.191** |
| sc2 | − 0.319** | − 0.458** | − 0.040** | − 0.028** |
| sc3 | − 1.315** | − 2.293** | − 0.163** | − 0.139** |
| ua2 | − 0.683** | − 0.949** | − 0.085** | − 0.058** |
| ua3 | − 2.117** | − 3.474** | − 0.263** | − 0.211** |
| pd2 | − 1.125** | − 1.826** | − 0.140** | − 0.111** |
| pd3 | − 3.336** | − 5.995** | − 0.415** | − 0.363** |
| ad2 | − 0.849** | − 1.581** | − 0.106** | − 0.096** |
| ad3 | − 2.707** | − 5.175** | − 0.336** | − 0.314** |
| Pseudo | 52.16% | – | 52.16% | – |
| Observations | ||||
| Respondents | ||||
| AIC |
The rows represent the coefficient level dimensions (e.g. mo2 represents mobility level 2)
AIC Akaike Information Criterion, * indicates significance at the 5% level,** indicates significance at the 1% level
Rescaling factor mixed logit: 0.0606. Rescaling factor conditional logit: 0.1243, both based on linear mappings without constant
Results anchoring analyses
| Linear mapping | Linear mapping (no constant) | Rescaling on mean value state 33333 | |
|---|---|---|---|
| Coefficient | 0.0669 | 0.0606 | 0.0683 |
| Intercept | 1.0700 | – | – |
| R-squared | 89.22% | 95.38% | – |
| MAE (means 28 states) | 0.0897 | 0.0929 | 0.1108 |
| MAE (mild states) | 0.0506 | 0.0228 | 0.0279 |
| RMSE (means 28 states) | 0.1183 | 0.1244 | 0.1436 |
| RMSE (mild states) | 0.0573 | 0.0309 | 0.0383 |
cTTO composite time trade-off, MAE mean absolute error, RMSE root mean square error
MAE and RMSE of three different anchoring techniques; linear mapping, linear mapping without a constant and rescaling directly on the mean observed value for state 33333 in the cTTO data. MAEs/RMSEs are calculated on the mean cTTO values for the 28 health states in the health state design (fourth/sixth row) and the means for the mild health states, which have at most one level 3 or two level 2 problems (fifth/seventh row)
Fig. 2Scatter plots for the predicted, rescaled DCE values and the mean observed cTTO values for the 28 health states included in the health state design, for all three anchoring strategies.
Fig. 3Values for all 243 health states, generated through either DCE (mixed logit model rescaled on the mean cTTO value for state 33333) or cTTO responses (heteroskedastic model without constant)
| This study generated a value set for the EQ-5D-Y-3L instrument using a standardised protocol, which enables the use of utility index scores in economic evaluations in paediatric populations in the Netherlands. |
| Both composite time trade-off data and discrete choice experiment data were collected, and modelled independently. The discrete choice experiment data were used for the final value set, with the composite time trade-off data being used to anchor the discrete choice experiment values onto the quality-adjusted life-year scale. |
| Pain and feeling worried, sad or unhappy were identified as the most important health dimensions, with looking after yourself receiving the smallest weight. |